StreetInsider.com News Articles

Brink’s Schedules Third-Quarter 2026 Earnings Release and Conference Call for November 4, 2026

Wed, 14 Oct 2026 16:14:00 -0400

RICHMOND, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services, will host a conference call on Wednesday, November 4, at 9:00 a.m. (EST) to review third-quarter 2026 financial results, which will be released earlier that morning.

The conference call can be accessed by calling 888-349-0094 (in the U.S.) or 412-902-0124 (international). Participants should join at least five minutes prior to the start of the call.

Participants can pre-register at https://dpregister.com/sreg/10211784/104d0077238 to receive a direct

Brink’s Schedules Third-Quarter 2026 Earnings Release and Conference Call for November 4, 2026

Wed, 14 Oct 2026 16:14:00 -0400

The conference call can be accessed by calling 888-349-0094 (in the U.S.) or 412-902-0124 (international). Participants should join at least five minutes prior to the start of the call.

Participants can pre-register at https://dpregister.com/sreg/10211784/104d0077238 to receive a direct

Form 8-K BRINKS CO For: Oct 08

Thu, 08 Oct 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20261008/27163106.html

Brink's gets CMA approval in principle for NCR Atleos deal remedy

Thu, 08 Oct 2026 05:10:11 -0400

The Brink's Company (NYSE: BCO) announced that the United Kingdom's Competition and Markets Authority (CMA) has accepted in principle its proposed remedy related to its planned acquisition of NCR Atleos Corporation (NYSE: NATL).

The proposed remedy involves the divestiture of NoteMachine/TestLink UK, which Brink's says would serve as an undertaking in lieu of a Phase 2 investigation referral by the CMA. Brink's stated it is engaged with prospective buyers and is working to conclude the divestiture in a timely manner.

According to Brink's President and Chief Executive Officer Mark Eubanks, the potential sale of NoteMachine/TestLink UK "was a remedy that was contemplated

Brink's gets CMA approval in principle for NCR Atleos deal remedy

Thu, 08 Oct 2026 05:10:11 -0400

According to Brink's President and Chief Executive Officer Mark Eubanks, the potential sale of NoteMachine/TestLink UK "was a remedy that was contemplated

Brink's gets UK antitrust approval to divest unit in NCR Atleos deal

Thu, 08 Oct 2026 05:09:33 -0400

The Brink's Company (NYSE: BCO) announced that the United Kingdom's Competition and Markets Authority (CMA) has accepted in principle its proposed remedy for the planned acquisition of NCR Atleos Corporation (NYSE: NATL).

The remedy involves the divestiture of NoteMachine/TestLink UK, which Brink's proposed as an alternative to a Phase 2 investigation by the CMA. Brink's stated it is working to select a suitable buyer and complete the divestiture process in a timely manner. As of Sept. 30, 2026, Brink's said the sale process was progressing and that it remained engaged with a number of prospective buyers.

Mark Eubanks, President and Chief Executive

Brink's gets UK antitrust approval to divest unit in NCR Atleos deal

Thu, 08 Oct 2026 05:09:33 -0400

Mark Eubanks, President and Chief Executive

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:20 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) announced today that the United Kingdom's Competition and Markets Authority ("CMA") has accepted in principle Brink’s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”).